Xvivo Perfusion
Develops machine perfusion technology for ex-vivo organ preservation.
XVIVO | ST
Overview
Corporate Details
- ISIN(s):
- SE0004840718 (+1 more)
- LEI:
- 549300G2464FYLS14B41
- Country:
- Sweden
- Address:
- Gemenskapens Gata 9, 431 53 Mölndal
- Website:
- https://www.xvivogroup.com/
- Sector:
- Manufacturing
Description
Xvivo Perfusion is a medical technology company specializing in ex-vivo organ preservation for transplantation. The company develops machine perfusion technologies, solutions, and services designed to extend the life of major organs, including lungs, livers, and kidneys. Its core technology, organ perfusion, is an alternative to static cold storage that continuously supplies an organ with an oxygenated solution while it is outside the body. This process helps support cellular function, prevent tissue damage, and allows clinicians to assess organ viability prior to transplant. The company's objective is to increase organ utilization, extend preservation times, and improve patient outcomes. Key products include the XPS™ for lung perfusion, Liver Assist™, Kidney Assist Transport™, and the PERFADEX® Plus solution for lung preservation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-23 07:30 | Swedish | 2.1 MB | |||
| 2025-10-23 07:30 | English | 2.0 MB | |||
| 2025-08-08 10:01 | Swedish | 9.5 KB | |||
| 2025-07-28 22:10 |
Fördröjning i CE-godkännandeprocessen för XVIVOs perfusionslösning för hjärtpre…
|
Swedish | 64.3 KB | ||
| 2025-07-28 22:10 |
Delay in CE approval for XVIVO’s perfusion solution for heart preservation
|
English | 63.6 KB | ||
| 2025-07-11 07:30 | Swedish | 2.0 MB | |||
| 2025-07-11 07:30 | English | 2.0 MB | |||
| 2025-04-25 14:25 |
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
|
Swedish | 59.6 KB | ||
| 2025-04-25 14:25 |
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
|
English | 60.1 KB | ||
| 2025-04-24 07:30 | Swedish | 1.9 MB | |||
| 2025-04-24 07:30 | English | 6.8 MB | |||
| 2025-04-02 19:30 | Swedish | 41.0 MB | |||
| 2025-03-20 17:45 |
Notice to attend the annual general meeting in XVIVO Perfusion AB (publ)
|
English | 111.0 KB | ||
| 2025-03-20 17:45 |
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
|
Swedish | 108.6 KB | ||
| 2025-01-28 07:30 | Swedish | 1.2 MB |
Automate Your Workflow. Get a real-time feed of all Xvivo Perfusion filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Xvivo Perfusion
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Xvivo Perfusion via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-28 | Lena Hagman | Other | Buy | 1,500 | 466,500.00 SEK |
| 2024-11-25 | Christoffer Björn Rosenblad | Other | Sell | 2,000 | 915,000.00 SEK |
| 2024-02-29 | Kristoffer Nordström | Other | Buy | 335 | 88,440.00 SEK |
| 2023-11-14 | Gösta Johannesson | Other | Buy | 500 | 124,500.00 SEK |
| 2023-04-24 | Lars Henriksson | Other | Buy | 400 | 107,200.00 SEK |
| 2022-11-02 | Gösta Johannesson | Other | Buy | 200 | 34,000.00 SEK |
| 2022-11-01 | Gösta Johannesson | Other | Buy | 1,000 | 166,500.00 SEK |
| 2022-08-19 | Dag Andersson Tilk | Other | Buy | 499 | 99,700.20 SEK |
| 2022-05-24 | Dag Andersson Tilk | Other | Other | 5,417 | 1,115,251.96 SEK |
| 2022-05-24 | Christoffer Björn Rosenblad | Other | Other | 2,708 | 557,523.04 SEK |
Peer Companies
